Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishnupriyadevi Parvathareddy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA Health Forum|October 11, 2022
How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets?Vishnupriyadevi Parvathareddy, Kevin F Erickson
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2025
Advanced Practice Provider Residency Program to Strengthen the Kidney Health WorkforceVishnupriyadevi Parvathareddy, Anitha Vijayan, Ashley Penrod, et al.
Medical Care|September 18, 2023
Market Competition and Anemia Management in the United States Following Dialysis Payment ReformAnshul Bhatnagar, Vishnupriyadevi Parvathareddy, Wolfgang C Winkelmayer, et al.
Cancers|November 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor ResponseVishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA Health Forum|October 11, 2022
How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets?Vishnupriyadevi Parvathareddy, Kevin F Erickson
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2025
Advanced Practice Provider Residency Program to Strengthen the Kidney Health WorkforceVishnupriyadevi Parvathareddy, Anitha Vijayan, Ashley Penrod, et al.
Medical Care|September 18, 2023
Market Competition and Anemia Management in the United States Following Dialysis Payment ReformAnshul Bhatnagar, Vishnupriyadevi Parvathareddy, Wolfgang C Winkelmayer, et al.
Cancers|November 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor ResponseVishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, et al.
Pageof 1